Learn More
Medchemexpress LLC Tisolagiline monomethylsulfate | 1894207-45-4 | 99.8% | 10 MG

Supplier: Medchemexpress LLC HY127109A10MG
Tisolagiline monomethylsulfate (KDS2010) is a selective, reversible, and orally active inhibitor for MAO-B with an IC50 of 8 nM. It exhibits neuroprotective and anti-neuroinflammatory activities. It reduces glial fibrillary acidic protein (GFAP) expression and glycosaminoglycan (CSPGs) deposition, thereby inhibiting astrocyte activation and scar formation.
- Ameliorates MPTP-induced Parkinson's disease in mouse models, alleviating motor dysfunction.
- Reverses reduction in TH-positive neurons and reduces GFAP and iNOS expression.
- Inhibits astrocyte scar formation.
- Increases doxorubicin penetration into glioblastoma domains and glioblastoma tumor volume in mouse models.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.